Searched for
GLENMARK PHARMA FDA
Glenmark Pharma shares up 2% after FDA grants fast track status to cancer drugGlenmark Pharma's innovation arm, IGI, received FDA fast track designation for its myeloma therapy ISB 2001, targeting heavily pre-treated ...- Stocks in news: HFCL, BHEL, Glenmark Pharma, ABFRL, WiproPiramal Enterprises Board approved the issuance of secured, rated, listed, and redeemable non-convertible debentures (NCDs) worth up to Rs ...
- Deutsche Bank upgrades Pharma sectorPharma sector stocks have been one of the worst performer on the bourses in last one year. BSE Healthcare index just risen a percent in the...
- Glenmark Pharma gets USFDA nod for two generic drugsQuoting IMS data, Glenmark Pharma said the approved product has an estimated market size of $74.1 million for the 12 months ended November ...
- Dr Reddy's launches insomnia drug in US; Glenmark gets FDA nodThe company has started selling 1 mg, 2 mg and 3 mg tablets of Eszopiclone, a generic version of Lunesta, a sedative drug that is used for ...
- Pharma companies grapple with rise in other expensesThe other expenses of these companies rose at a much higher pace than their revenues over the last three years, says a study.
- UCB files cases against Ranbaxy, Aurobindo, Glenmark, Sun Pharma, others on patent issueUCB alongwith others has filed separate cases against as many as 15 drug makers for allegedly infringing its patented drug Vimpat.
- Glenmark gets USFDA approval for sclerosis treatment drugDrug firm Glenmark Pharmaceuticals today said it has received US health regulator's approval to market Riluzole tablets.
- Indian pharma companies like Aurobindo and Glenmark set to gain from USFDA nod for asthma drugIndian drug makers are set to benefit from a decision by the USFDA to allow sale of generic Singulair tablets used for treating asthma and ...
- Glenmark Pharmaceuticals to initiate filing for Crofelemer as Salix submits NDAGlenmark is going full steam ahead with the launch of Crofelemer post the issue of Napo Pharma's claim of termination of the deal.
- Glenmark most promising in pharma pack: Networth Stock BrokingGlenmark is one stock that we particularly like because it has the FDA filing which it has gone ahead.
- Positive on Glenmark Pharma and Ipca Laboratories: Avinash GorakshekarWe believe that Glenmark's top line for the next two years based on the kind of research pipeline, which they have would definitely aid a 2...
- Glenmark gets a boost in cholesterol drug battle with MerckGlenmark Pharmaceuticals has gained the upper hand in a legal battle against Merck over a cholesterol control pill after a US court rejecte...
- Glenmark gets USFDA nod for anti-hypertension tabletsGlenmark Pharmaceuticals today said its American subsidiary has received the final approval from the US Food and Drug Administration (FDA) ...
- Orchid, Glenmark, Lupin & Aurobindo Pharma get US nod for LevetiracetamOrchid Pharmaceuticals, Glenmark Pharmaceuticals, Lupin and Aurobindo Pharmaceuticals have all received US FDA approval for their abbreviat...
- Glenmark gets $15 mn milestone payment from Forest LabsAfter a long wait, Glenmark Pharma has finally received a second milestone payment of $15 million from Forest Laboratories for its asthma e...
- Sanofi, Abbott file lawsuit against GlenmarkSanofi-Aventis SA and Abbott Laboratories have jointly filed a lawsuit against Glenmark to prevent the Indian company from selling its hype...
- Glenmark gets US nod for drug trialsEnding a long wait for Glenmark Pharmaceuticals, the US Food and Drug Administration (FDA) finally gave its nod to the Indian drugmaker to ...
- Glenmark gets nod to sell Zofran generic in USGlenmark Pharmaceuticals has received final approval to market a generic version of GlaxoSmithKline’s popular anti-emetic drug Zofran, that...
- Glenmark Pharma makes its presence felt in US marketGlenmark Pharmaceuticals is rapidly scaling up its US market product pipeline with its latest agreement with the US-based generic player.
Load More
